Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 6/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 6/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 3/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.35 |
| ▸ | PPARD | Q03181 | 2/20 | 0.35 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.35 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3883666 | 0.88 | CHRNA7 (0.42) | GRM2P2RX3 | |
| SCHEMBL3887928 | 0.88 | CHRNA7 (0.41) | GRM2SRC | |
| SCHEMBL3882068 | 0.87 | FFAR4 (0.47) | FFAR4PPARGGRM2S1PR1PPARA | |
| SCHEMBL3888290 | 0.86 | P2RX3 (0.38) | PPARGGRM2SRCP2RX3 | |
| SCHEMBL3892392 | 0.85 | P2RX3 (0.36) | PPARGGRM2SRCP2RX3 | |
| SCHEMBL3881933 | 0.84 | FFAR4 (0.43) | FFAR4PPARGGRM2PPARANR1H2 | |
| SCHEMBL3883330 | 0.82 | FFAR4 (0.45) | FFAR4PPARGGRM2S1PR1PPARA | |
| SCHEMBL3882409 | 0.80 | PTGER1 (0.42) | PPARGPPARAPPARDSRC | |
| SCHEMBL3890246 | 0.79 | PTGER1 (0.40) | PPARGPPARAPPARDSRCP2RX3 | |
| SCHEMBL3888819 | 0.79 | GRM2 (0.40) | FFAR4PPARGGRM2PPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1477472-B1 | SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF | ASAHI KASEI PHARMA CORP (JP) | 2009-01-14 | — | — | EP | claimed |